Author Correction: CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity. - Xiang Y; Mata-Garrido J; Fu Y; Desterke C; Batsché E; Hamaï A; Sedlik C; Sereme Y; Skurnik D; Jalil A; Onifarasoaniaina R; Frapy E; et al. (EMBO molecular medicine, 2024)